Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to $131000.0.

  • Viking Therapeutics' Non-Current Assets fell 8814.48% to $131000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year decrease of 4297.72%. This contributed to the annual value of $131000.0 for FY2025, which is 8814.48% down from last year.
  • Viking Therapeutics' Non-Current Assets amounted to $131000.0 in Q4 2025, which was down 8814.48% from $712000.0 recorded in Q3 2025.
  • In the past 5 years, Viking Therapeutics' Non-Current Assets ranged from a high of $1.7 million in Q1 2022 and a low of $131000.0 during Q4 2025
  • In the last 5 years, Viking Therapeutics' Non-Current Assets had a median value of $1.1 million in 2024 and averaged $992400.0.
  • In the last 5 years, Viking Therapeutics' Non-Current Assets skyrocketed by 101119.4% in 2022 and then tumbled by 8814.48% in 2025.
  • Over the past 5 years, Viking Therapeutics' Non-Current Assets (Quarter) stood at $134000.0 in 2021, then surged by 1011.19% to $1.5 million in 2022, then decreased by 15.04% to $1.3 million in 2023, then decreased by 12.65% to $1.1 million in 2024, then crashed by 88.14% to $131000.0 in 2025.
  • Its last three reported values are $131000.0 in Q4 2025, $712000.0 for Q3 2025, and $834000.0 during Q2 2025.